Russian Covid-19 vaccine developed an antibody response

Tell a friend about this post

All participants given a Russian Covid-19 vaccine developed an antibody response and suffered no serious adverse side effects in the early-stage trials, according to results published in The Lancet medical journal.

Experts said the trials were still too small and early to prove the vaccine’s effectiveness and safety – and noted that there had not been a placebo comparison.

The trial took place in two Russian hospitals and involved 76 healthy adults aged 18 to 60.

Each participant was given a dose of the first part of the vaccine and then given a booster with the second part 21 days later.

Read more

Tell a friend about this post
READ ALSO  The 10 Rules of And How Learn More

Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected!!!

We have detected that you are using extensions to block ads. Please support us by disabling these ads blocker.

Powered By
Best Wordpress Adblock Detecting Plugin | CHP Adblock

You cannot copy content of this page